Literature DB >> 24666240

The multidisciplinary management of giant cell tumor of bone.

Vincent Y Ng1, Darin J Davidson, Edward Y Kim, Seth M Pollack, Ernest U Conrad Iii, Robin L Jones.   

Abstract

Giant cell tumor of bone is a locally aggressive lesion with a predilection for local recurrence, and in a small proportion of patients, metastatic disease can develop. Surgery is the mainstay of management for extremity-based lesions. For tumors located in challenging anatomical locations such as the sacrum and spine however, surgery may be associated with unacceptable functional morbidity. There are limited data regarding other treatment modalities such as radiation therapy, cytotoxic chemotherapy, interferon and bisphosphonates. Serial arterial embolization can be effective in some cases. Recent evidence has demonstrated denosumab to be a promising agent in the treatment of unresectable or metastatic disease.

Entities:  

Keywords:  denosumab; giant cell; management; multi modality; osteoclast; receptor activator of nuclear factor κ-B; surgery

Mesh:

Substances:

Year:  2014        PMID: 24666240     DOI: 10.1586/14737140.2014.901891

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  8 in total

Review 1.  Integration of denosumab therapy in the management of giant cell tumors of bone.

Authors:  Daniel T Miles; Ryan T Voskuil; Wood Dale; Joel L Mayerson; Thomas J Scharschmidt
Journal:  J Orthop       Date:  2020-03-28

2.  Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage.

Authors:  Kun-Hui Chen; Po-Kuei Wu; Cheng-Fong Chen; Wei-Ming Chen
Journal:  Eur Spine J       Date:  2015-05-05       Impact factor: 3.134

Review 3.  Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence.

Authors:  Aneta Maria Borkowska; Anna Szumera-Ciećkiewicz; Bartłomiej Szostakowski; Andrzej Pieńkowski; Piotr Lukasz Rutkowski
Journal:  Cancers (Basel)       Date:  2022-05-04       Impact factor: 6.575

4.  Development and proposal of a scoring system for giant cell tumour of the bone around the knee.

Authors:  Deng-Xing Lun; Yong-Cheng Hu; Xiong-Gang Yang; Zhen Wang; Xiu-Chun Yu; Su-Jia Wu; Zhao-Ming Ye; Han Wang
Journal:  Int Orthop       Date:  2017-10-07       Impact factor: 3.075

5.  Combining of serial embolization and denosumab for large sacropelvic giant cell tumor: Case report of 3 cases.

Authors:  Tao Ji; Yi Yang; Yifei Wang; Kunkun Sun; Wei Guo
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

6.  A novel subchondral bone-grafting procedure for the treatment of giant-cell tumor around the knee: A retrospective study of 27 cases.

Authors:  Minhao Wu; Shiyi Yao; Yuanlong Xie; Feifei Yan; Zhouming Deng; Jun Lei; Lin Cai
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

7.  Outcome of lung metastases due to bone giant cell tumor initially managed with observation.

Authors:  Shinji Tsukamoto; Giovanni Ciani; Andreas F Mavrogenis; Cristina Ferrari; Manabu Akahane; Yasuhito Tanaka; Michele Rocca; Alessandra Longhi; Costantino Errani
Journal:  J Orthop Surg Res       Date:  2020-11-07       Impact factor: 2.359

Review 8.  Metastatic giant cell tumour of bone: a narrative review of management options and approaches.

Authors:  Ruiwen Xu; Peter F M Choong
Journal:  ANZ J Surg       Date:  2022-02-10       Impact factor: 2.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.